Les Kjosness, President & CEO, is pleased to announce Marapharm Ventures Inc. (the ’Company’), has contracted Bayside Management Corp. of Calgary, Alberta to complete all of the Company’s Investor Relations activities for one full year. The contract covers office and related expenses, all travel, brokerage communications and is payable with 560,000 Marapharm common shares based at seventy five cents ($0.75) per share. Bayside is aware the shares may have trading restrictions and are subject to regulatory approval.
Marapharm granted a total of two million options (2,000,000) to Company Directors, consultants and employees. The options are at a price of $0.50 and have a two year term.
On behalf of the Board
President & CEO
The CSE has neither approved nor disapproved the accuracy of this news release.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities – that could cause actual results to differ materially from the Company’s expectations are disclosed in the Companies’ documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward – looking statements, which speak only as of the date of this news release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward – looking statements, whether as a result of new information, future events or otherwise.